---
$id: https://graph.org.ai/products/commodity/51131740
$type: Product
source: UNSPSC
code: "51131740"
title: "Ticagrelor"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ticagrelor

**UNSPSC Code**: 51131740
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GLH0314RVC. European Medicines Agency schedules Ticagrelor in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30898. Ticagrelor generally arises in the molecular formula C23H28F2N6O4S. The term TICAGRELOR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, no. 1, 2007, list 57.) Most nations schedule ticagrelor under HS 29335990 and SITC 51576. As of Q4 2014, TICAGRELOR remains the US FDA Preferred Term for this commodity. Ticagrelor bears US NLM identifiers UMLS ID C1999375 and NCI Concept Code C76404. SMILES: CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO.

